PRESS RELEASE published on 07/15/2025 at 14:00, 1 year ago Eckert & Ziegler: Outstanding Training Quality Once Again Awarded Eckert & Ziegler SE awarded for exceptional training quality by Berlin Chamber of Industry and Commerce for the fourth consecutive time, emphasizing practical experience and career prospects for trainees Eckert & Ziegler Career Prospects Training Quality Berlin Chamber Of Industry And Commerce Trainee Team
BRIEF published on 06/18/2025 at 16:10, 1 year 1 month ago Eckert & Ziegler SE Declares EUR 0.50 Dividend at Annual General Meeting Annual General Meeting Shareholders Dividend Financial Year 2024 Eckert & Ziegler SE
PRESS RELEASE published on 06/18/2025 at 16:05, 1 year 1 month ago Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50 Eckert & Ziegler SE's Annual General Meeting approves dividend of EUR 0.50 per share for 2024 fiscal year. Detailed voting results available online Annual General Meeting Shareholders Voting Results Dividend Eckert & Ziegler SE
BRIEF published on 06/05/2025 at 10:05, 1 year 1 month ago Eckert & Ziegler Expands with Approval of Illuccix® in Germany Gallium-68 Nuclear Medicine Prostate Cancer Illuccix® PSMA-PET Imaging
PRESS RELEASE published on 06/05/2025 at 10:00, 1 year 1 month ago Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany Eckert & Ziegler announces the approval of Illuccix® PSMA-PET Imaging Agent in Germany, expanding its nuclear medicine portfolio and partnership with Telix Pharmaceuticals Eckert & Ziegler Germany Approval Illuccix PSMA-PET
BRIEF published on 05/30/2025 at 10:05, 1 year 2 months ago Eckert & Ziegler Hosts Successful Boston Radionuclide Theranostics Forum Precision Oncology Industry Collaboration Radiopharmaceuticals Theranostics Forum Event Insights
PRESS RELEASE published on 05/30/2025 at 10:00, 1 year 2 months ago Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum Eckert & Ziegler successfully completes the 3rd annual Boston Radionuclide Theranostics Forum, gathering key leaders to discuss radionuclides in precision oncology Innovation Eckert & Ziegler Precision Oncology Radiopharmaceuticals Boston Radionuclide Theranostics Forum
BRIEF published on 05/23/2025 at 10:05, 1 year 2 months ago Eckert & Ziegler Receives Prestigious Management Award Again Eckert & Ziegler Nuclear Medicine Best Managed Companies Deloitte Private Isotopes
PRESS RELEASE published on 05/23/2025 at 10:00, 1 year 2 months ago Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time Eckert & Ziegler SE wins the 'Best Managed Companies Award' for the second time, recognizing their excellence in strategy, productivity, innovation, culture, finance, and governance Eckert & Ziegler SE Nuclear Medicine Best Managed Companies Award Deloitte Private UBS
BRIEF published on 05/13/2025 at 07:50, 1 year 2 months ago Eckert & Ziegler Reports Q1 2025 Revenue Growth and Upholds Yearly Outlook Revenue Growth Medical Segment Isotope Products 2025 Forecast Q1 2025 Earnings
Published on 07/31/2026 at 08:00, 12 minutes ago Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 07/31/2026 at 01:39, 6 hours 33 minutes ago Transition from OTCQB to Unsponsored OTC Quotation
Published on 07/30/2026 at 23:45, 8 hours 27 minutes ago Namibia Critical Metals Announces Completion of Japan's C$23 Million Earn-In and Formation of Strategic Joint Venture Company for the Lofdal Heavy Rare Earth Project
Published on 07/30/2026 at 23:01, 9 hours 11 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended June 30, 2026 and Management Changes
Published on 07/30/2026 at 23:00, 9 hours 12 minutes ago Eagle Plains Announces Approval of Warrant Expiry Extension
Published on 07/31/2026 at 08:00, 12 minutes ago Transformation continues: CENIT shows increased profitability in the first half year 2026
Published on 07/31/2026 at 08:00, 12 minutes ago PUMA Q2 2026 reflects reset measures and softer demand - Strong free cash flow - FY 2026 outlook confirmed
Published on 07/31/2026 at 07:30, 42 minutes ago SURTECO GROUP SE: Sales and earnings within the target corridor; rise in adjusted and reported EBITDA; forecast confirmed
Published on 07/31/2026 at 07:30, 42 minutes ago R. STAHL publishes half-year results – Sales and profitability in line with planning – Forecast for 2026 confirmed
Published on 07/30/2026 at 18:15, 13 hours 56 minutes ago Publication of the 2026 half-year financial report
Published on 07/30/2026 at 18:00, 14 hours 12 minutes ago PR ICADE – ACQUISITION OF A CONTROLLING INTEREST IN COMET
